BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $329K of BioMarin Pharmaceutical Inc.
Sold$328,625
$82.16Price
4,000Shares
−1%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Wed, May 8. Filed Thu, May 9, 8:32 PM ET, after the close. Not investment advice.